Max Healthcare Insti...
BSE:543220
Rp 993,65
Rp-6,95 (-0,69%)
993,65 Rp
Rp-6,95 (-0,69%)
End-of-day quote: 05/27/2026

Max Healthcare Institute Stock Value

Analysts currently give BSE:543220 a rating of Outperform.
Outperform
Outperform

Max Healthcare Institute Company Info

EPS Growth 5Y
55,68%
Market Cap
Rp973,83 B
Long-Term Debt
Rp24,39 B
Quarterly earnings
05/21/2026
Dividend
Rp1,99
Dividend Yield
0,20%
Founded
2001
Industry
Country
ISIN Number

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Rp1.215,00
22.28%
22.28
Last Update: 05/21/2026
Analysts: 25

Highest Price Target Rp1.475,00

Average Price Target Rp1.215,00

Lowest Price Target Rp825,00

In the last five quarters, Max Healthcare Institute’s Price Target has risen from Rp979,72 to Rp1.084,75 - a 10,72% increase. Twenty Five analysts predict that Max Healthcare Institute’s share price will increase in the coming year, reaching Rp1.215,00. This would represent an increase of 22,28%.

Top growth stocks in the health care sector (5Y.)

What does Max Healthcare Institute do?

Max Healthcare Institute Limited is a provider of comprehensive healthcare services in India, dedicated to delivering medical care across various specialties. The company operates a network of hospitals, clinics, and diagnostic centers, offering a wide array of healthcare services that encompass diagnostics and lab services, ambulatory care, consultations, surgical and non-surgical procedures, and medical care. The company focuses on a patient-centered approach, ensuring that each individual rec...

Max Healthcare Institute Questions and Answers

Which sectors generate sales and which are the top 3 markets?
**healthcare services:** 70% **medical devices and technologies:** 20% **pharmaceutical services:** 10% **top 3 markets:** 1. **india:** 60% 2. **middle east:** 25% 3. **southeast asia:** 15% max healthcare institute limited generates the majority of its revenue from the healthcare s...
At which locations are the company’s products manufactured?
**production sites:** india (2025) max healthcare institute limited is a leading provider of healthcare services in india. the company operates a variety of hospitals and medical facilities in different cities across the country. the services and products offered by max healthcare are mainly produc...
What strategy does Max Healthcare Institute pursue for future growth?
**revenue growth:** estimated 10-12% annually (2025-2027) **expansion strategy:** expansion of capacities in existing facilities and exploration of new markets max healthcare institute limited pursues a growth strategy based on expanding its capacities in existing facilities and exploring new geog...
Which raw materials are imported and from which countries?
**main imported raw materials/items:** medical devices, pharmaceutical products, diagnostic equipment **main import countries:** usa, germany, japan max healthcare institute limited imports a variety of medical devices and pharmaceutical products that are necessary for the operation of their healt...
How strong is the company’s competitive advantage?
**market share:** 12% (2024, estimated) **ebitda margin:** 23% (2024) **net profit margin:** 10% (2024) max healthcare institute limited has a significant competitive advantage in the indian healthcare sector, underscored by its strong market presence and financial performance. the company ha...
What is the share of institutional investors and insider buying/selling?
**institutional investor share:** approximately 45% (2025, estimated value based on historical data) **insider buys/sells:** no significant transactions in the last year (2024) the institutional investor share in max healthcare institute limited is estimated to be around 45%. this demonstrates the...
What percentage market share does Max Healthcare Institute have?
**market share of max healthcare institute limited:** 12% (2025, estimated) **top competitors and their market shares:** 1. apollo hospitals enterprise limited - 18% 2. fortis healthcare limited - 15% 3. narayana health - 10% 4. manipal hospitals - 9% 5. aster dm healthcare - 8% **moat of max heal...
Is Max Healthcare Institute stock currently a good investment?
**revenue growth:** 18% (2024) **profit growth:** 20% (2024) **ebitda margin:** 25% (2024) max healthcare institute limited recorded strong revenue growth of 18% in 2024, attributed to increased demand for healthcare services and successful expansion into new markets. the 20% profit growth in the s...
Does Max Healthcare Institute pay a dividend – and how reliable is the payout?
**dividend:** 2.5 inr per share (2024) max healthcare institute limited distributed a dividend of 2.5 inr per share in 2024. the company has been following a consistent dividend policy in recent years, indicating a certain reliability in the distribution. the stability of dividend payments is ofte...
×